Burundi has officially introduced the malaria vaccine into its routine immunization program, a major step in combating the disease and saving children’s lives. The initiative, led by the Ministry of Health with support from Gavi, UNICEF, WHO, and Dalberg, was launched in Mpanda District, attended by First Lady Angeline Ndayishimiye.
Following the arrival of 544,000 doses in January, the vaccine was approved by ABREMA, reinforcing Burundi’s commitment to fighting malaria. The disease remains a major health concern, with over 4.8 million cases reported in 2023, nearly half affecting children under five.
“This milestone demonstrates our dedication to reducing malaria deaths and protecting our children,” said Health Minister Dr. Lydwine Baradahana. Experts from Gavi, WHO, and UNICEF emphasized the vaccine’s role in reducing illness and deaths, complementing existing prevention measures like mosquito nets and seasonal chemoprevention.
Partners have supported vaccine rollout through training, communication strategies, and ensuring adequate cold chain systems. This initiative places Burundi among 18 African nations introducing the malaria vaccine, bringing hope for a healthier future.
